Sanskar Chemicals And Drugs Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.82 M
- Company Age 25 Year, 6 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.20 Cr
- Revenue Growth -35.00%
- Profit Growth -168.14%
- Ebitda -56.04%
- Net Worth -97.29%
- Total Assets -7.32%
About Sanskar Chemicals And Drugs
Sanskar Chemicals And Drugs Private Limited (SCADPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 February 2000 and has a history of 25 years. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.82 M.
The company has closed loans amounting to ₹1.20 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dinesh Kumar and Deepak Abhayakumar serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24111TN2000PTC044076
-
Company No.
044076
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Feb 2000
-
Date of AGM
24 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Sanskar Chemicals And Drugs?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dinesh Kumar | Director | 02-Feb-2000 | Current |
Deepak Abhayakumar | Director | 03-Apr-2019 | Current |
Financial Performance of Sanskar Chemicals And Drugs.
Sanskar Chemicals And Drugs Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 35% decrease. The company also saw a substantial fall in profitability, with a 168.14% decrease in profit. The company's net worth observed a substantial decline by a decrease of 97.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sanskar Chemicals And Drugs?
In 2020, Sanskar Chemicals And Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹12.00 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.20 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
11 Sep 2009 | State Bank Of India | ₹1.20 Cr | Satisfied |
How Many Employees Work at Sanskar Chemicals And Drugs?
Sanskar Chemicals And Drugs has a workforce of 35 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanskar Chemicals And Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanskar Chemicals And Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.